- Home
- LASR vs EYPT Comparison
LASR vs EYPT Comparison
Compare LASR & EYPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LASR
- EYPT
- Stock Information
- Founded
- LASR 2000
- EYPT 1987
- Country
- LASR United States
- EYPT United States
- Employees
- LASR N/A
- EYPT N/A
- Industry
- LASR Semiconductors
- EYPT Biotechnology: Laboratory Analytical Instruments
- Sector
- LASR Technology
- EYPT Industrials
- Exchange
- LASR Nasdaq
- EYPT Nasdaq
- Market Cap
- LASR 903.8M
- EYPT 967.4M
- IPO Year
- LASR 2018
- EYPT 2005
- Fundamental
- Price
- LASR $31.77
- EYPT $11.76
- Analyst Decision
- LASR Strong Buy
- EYPT Strong Buy
- Analyst Count
- LASR 6
- EYPT 5
- Target Price
- LASR $27.42
- EYPT $27.40
- AVG Volume (30 Days)
- LASR 676.4K
- EYPT 1.4M
- Earning Date
- LASR 11-06-2025
- EYPT 11-05-2025
- Dividend Yield
- LASR N/A
- EYPT N/A
- EPS Growth
- LASR N/A
- EYPT N/A
- EPS
- LASR N/A
- EYPT N/A
- Revenue
- LASR $216,913,000.00
- EYPT $51,898,000.00
- Revenue This Year
- LASR $23.44
- EYPT N/A
- Revenue Next Year
- LASR $8.73
- EYPT N/A
- P/E Ratio
- LASR N/A
- EYPT N/A
- Revenue Growth
- LASR 9.79
- EYPT 2.99
- 52 Week Low
- LASR $6.20
- EYPT $3.91
- 52 Week High
- LASR $33.96
- EYPT $14.91
- Technical
- Relative Strength Index (RSI)
- LASR 53.52
- EYPT 42.93
- Support Level
- LASR $29.49
- EYPT $11.15
- Resistance Level
- LASR $33.91
- EYPT $12.47
- Average True Range (ATR)
- LASR 1.52
- EYPT 0.68
- MACD
- LASR -0.02
- EYPT -0.08
- Stochastic Oscillator
- LASR 55.42
- EYPT 23.37
About LASR nLIGHT Inc.
nLight Inc is a United States-based company provider of power semiconductor and fiber lasers for aerospace and defense, industrial, and microfabrication applications. It designs, manufactures, and sells a range of power semiconductor lasers and fiber lasers that are typically integrated into laser systems. It operates in two segments: Laser Products, which includes semiconductor lasers, fiber lasers, and directed energy products; and Development segment includes revenue earned from research and development contracts. The majority of its revenue is generated from the Laser segment. The company's geographical segments include North America, Asia Pacific, and EMEA.
About EYPT EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.